First in Human feasibility and sfafety study of the alfapump DSR system in the treatment of Heart failure subects resistant to diuretic therapy. Up to 10 subjects will be enrolled in up to 3 centres in Belgium and Georgia and will be iplanted with the alfapump DSR system. Subjects will undergo DSR titration during a 2 week hospitalisation period, and will continue titrated DSR therapy as outpatients for 4 more weeks.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety in-hospital - Device related
Timeframe: Through Day 14 of treatment period
Safety in-hospital - therapy related
Timeframe: Through Day 14 of treatment period
Safety in-hospital - procedure related
Timeframe: Through Day 14 of treatment period
Safety during treatment period - device related
Timeframe: through Day 42 of treatment period
Safety during treatment period - procedure related
Timeframe: through Day 42 of treatment period
Safety during treatment period - therapy related
Timeframe: through Day 42 of treatment period